L-甲状腺氨酸结构式
|
常用名 | L-甲状腺氨酸 | 英文名 | thyronine |
---|---|---|---|---|
CAS号 | 1596-67-4 | 分子量 | 273.284 | |
密度 | 1.3±0.1 g/cm3 | 沸点 | 477.7±45.0 °C at 760 mmHg | |
分子式 | C15H15NO4 | 熔点 | 259-260℃ | |
MSDS | 中文版 美版 | 闪点 | 242.7±28.7 °C |
L-甲状腺氨酸用途L-胸腺嘧啶核苷是一种去离子甲状腺素。 |
中文名 | L-甲状腺氨酸 |
---|---|
英文名 | L-thyronine |
中文别名 | L-原氨酸 |
英文别名 | 更多 |
密度 | 1.3±0.1 g/cm3 |
---|---|
沸点 | 477.7±45.0 °C at 760 mmHg |
熔点 | 259-260℃ |
分子式 | C15H15NO4 |
分子量 | 273.284 |
闪点 | 242.7±28.7 °C |
精确质量 | 273.100098 |
PSA | 92.78000 |
LogP | 2.25 |
蒸汽压 | 0.0±1.3 mmHg at 25°C |
折射率 | 1.634 |
储存条件 | -15°C |
计算化学 | 1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:3 3.氢键受体数量:5 4.可旋转化学键数量:5 5.互变异构体数量:2 6.拓扑分子极性表面积92.8 7.重原子数量:20 8.表面电荷:0 9.复杂度:307 10.同位素原子数量:0 11.确定原子立构中心数量:1 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
安全声明 (欧洲) | 22-24/25 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
海关编码 | 2922509090 |
~% L-甲状腺氨酸 1596-67-4 |
文献:Biochemical Journal, , vol. 28, p. 68,71 |
~% L-甲状腺氨酸 1596-67-4 |
文献:Biochemical Journal, , vol. 28, p. 68,71 |
~% L-甲状腺氨酸 1596-67-4 |
文献:Biochemical Journal, , vol. 28, p. 68,71 |
~% L-甲状腺氨酸 1596-67-4 |
文献:Biochemical Journal, , vol. 28, p. 68,71 |
~% L-甲状腺氨酸 1596-67-4 |
文献:Biochemical Journal, , vol. 28, p. 68,71 |
~% L-甲状腺氨酸 1596-67-4 |
文献:Biochemical Journal, , vol. 28, p. 68,71 |
~% L-甲状腺氨酸 1596-67-4 |
文献:Biochemical Journal, , vol. 28, p. 68,71 |
~% L-甲状腺氨酸 1596-67-4 |
文献:Biochemical Journal, , vol. 28, p. 68,71 |
~% L-甲状腺氨酸 1596-67-4 |
文献:Biochemical Journal, , vol. 28, p. 68,71 |
L-甲状腺氨酸上游产品 5 | |
---|---|
L-甲状腺氨酸下游产品 0 |
海关编码 | 2922509090 |
---|---|
中文概述 | 2922509090. 其他氨基醇酚、氨基酸酚及其他含氧基氨基化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:AB. 最惠国关税:6.5%. 普通关税:30.0% |
申报要素 | 品名, 成分含量, 用途, 乙醇胺及其盐应报明色度, 乙醇胺及其盐应报明包装 |
监管条件 | A.入境货物通关单 B.出境货物通关单 |
检验检疫 | R.进口食品卫生监督检验 S.出口食品卫生监督检验 |
Summary | 2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Impact of hydration state and molecular oxygen on the chemical stability of levothyroxine sodium.
Pharm. Dev. Technol. 20(3) , 314-9, (2015) Levothyroxine sodium is an important medication used primarily for treating patients with hypothyroidism. Levothyroxine sodium tablets have been recalled many times since their 1955 introduction to th... |
|
Immunoexpressions of embryonic and nonembryonic stem cell markers (Nanog, Thy-1, c-kit) and cellular connections (connexin 43 and occludin) on testicular tissue in thyrotoxicosis rat model.
Hum. Exp. Toxicol. 34 , 601-11, (2015) In this study, possible thyrotoxicosis-related histological changes in testicular tissues of rats with experimentally induced thyrotoxicosis model were evaluated on cellular connections and stem cell ... |
|
A Convenient and Efficient Method to Enrich and Maintain Highly Proliferative Human Fetal Liver Stem Cells.
Rejuvenation Res. 18 , 211-24, (2015) Pluripotent human hepatic stem cells have broad research and clinical applications, which are, however, restricted by both limited resources and technical difficulties with respect to isolation of ste... |
thyronine |
(2S)-2-amino-3-[4-(4-hydroxyphenoxy)phenyl]propanoic acid |
Tyrosine, O-(4-hydroxyphenyl)- |
l-thyronine |
Desiodothyroxine |
O-(4-Hydroxyphenyl)tyrosine |
MFCD00063070 |
EINECS 216-483-8 |